STOCK TITAN

Pacira BioSciences to Participate in Fireside Chat at the Jefferies Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Pacira BioSciences, Inc. (NASDAQ: PCRX) will participate in an analyst-led fireside chat at the Jefferies Healthcare Conference on June 9, 2022, at 9:00 AM ET in New York. The live audio of the event can be accessed via the company's website, and a replay will be available for two weeks thereafter.

Pacira is dedicated to providing non-opioid treatment options, including three commercial-stage products: EXPAREL, ZILRETTA, and ioveraº. The company aims to redefine opioid usage and address chronic pain and other debilitating conditions.

Positive
  • None.
Negative
  • None.

TAMPA, Fla., June 02, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Jefferies Healthcare Conference at 9:00 AM ET on Thursday, June 9, 2022 in New York. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain, and spasticity. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesia currently approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.


FAQ

What time is Pacira's fireside chat at the Jefferies Healthcare Conference?

Pacira's fireside chat is scheduled for June 9, 2022, at 9:00 AM ET.

Where can I listen to the live audio of the Pacira event?

The live audio can be accessed on the 'Events' page of Pacira's website.

How long will the replay of the Pacira fireside chat be available?

The replay will be available for two weeks after the event.

What are the main products of Pacira BioSciences?

Pacira's main products include EXPAREL, ZILRETTA, and ioveraº.

What is the focus of Pacira BioSciences?

Pacira focuses on providing non-opioid treatment options and addressing chronic pain.

Pacira BioSciences, Inc.

NASDAQ:PCRX

PCRX Rankings

PCRX Latest News

PCRX Stock Data

1.14B
45.13M
2.15%
114.51%
10.29%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
TAMPA